Jeff Osborne, president and CEO of Accumen, expressed excitement about the deal.
“Chi and Accumen bring a new level of capacity and capability to laboratories across the U.S. to accelerate breakthrough performance,” he said in a prepared statement. “With healthcare payment and delivery reform continuing to drive value-based healthcare, Accumen and Chi are well positioned to meet the needs and opportunities in the laboratory using proven results and successful partnership models.”
Kathleen Murphy, MD, CEO of Chi, echoed Mr. Osborne, saying, “At no time in our history has a partnership been as complimentary, as transformative, or as powerful as the combination of Accumen and Chi. This power translates to more value for our clients, better opportunity for our employees, and the creation of best-in-class provider for our industry.”
More articles on healthcare industry transactions:
CHS acquires majority stake in Arkansas hospital
HCA completes purchase of bankrupt Texas hospital
Alpena Regional joins MidMichigan Health
